+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Morphine"

Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 84 Pages
  • Global
From
From
From
Demerol Meperdine - Global Strategic Business Report - Product Thumbnail Image

Demerol Meperdine - Global Strategic Business Report

  • Report
  • September 2025
  • 287 Pages
  • Global
From
Opioids - Global Strategic Business Report - Product Thumbnail Image

Opioids - Global Strategic Business Report

  • Report
  • September 2025
  • 189 Pages
  • Global
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • September 2025
  • 578 Pages
  • Global
From
Opioid Kappa Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Kappa Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peripheral Neuropathic Pain-Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain-Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Postoperative Pain Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Postoperative Pain Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Acute Pain Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Acute Pain Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Postoperative Pain Management Pipeline Analysis Report 2025 - Product Thumbnail Image

Postoperative Pain Management Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Acute Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Acute Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Opioid Addiction: Opportunity Assessment and Forecast - Product Thumbnail Image

Opioid Addiction: Opportunity Assessment and Forecast

  • Report
  • October 2024
  • 80 Pages
  • Global
From
Loading Indicator

Morphine is an analgesic drug used to treat moderate to severe pain. It is a member of the opioid family, and is derived from the opium poppy plant. Morphine is available in a variety of forms, including tablets, capsules, syrups, and injectable solutions. Morphine is often used in the treatment of cancer pain, post-operative pain, and chronic pain. It is also used to treat acute pain, such as that caused by a heart attack or stroke. Morphine is generally considered to be a safe and effective analgesic, but it can cause side effects such as nausea, vomiting, constipation, and drowsiness. Morphine is available in both generic and brand-name formulations. Some of the major companies in the market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more